PharmaNeuroBoost N.V. Report issue

For profit Phase 3
Founded: Alken Belgium (2006)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2008
NCT00672659
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Pharmaneuroboost N.V. Alkerstraat 30A B-3570 Alken, Belgium

Active Ingredients

Drugs in Phase 3 Trials (2)

citalopram (celexa) (2 trials)

pipamperone hydrochloride (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Major (Phase 3)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2